762 papers found
Refreshing results…
Increased frequencies of CD11b(+)CD33(+)CD14(+)HLA-DRlow myeloid-derived suppressor cells are an early event in melanoma patients
Neutrophilic disease of the skin and intestines after ipilimumab treatment for malignant melanoma – simultaneous occurrence of pyoderma gangrenosum and colitis
26. Mainzer Allergie-Workshop
A Trifunctional Dextran-Based Nanovaccine Targets and Activates Murine Dendritic Cells, and Induces Potent Cellular and Humoral Immune Responses In Vivo
Solution Properties and Potential Biological Applications of Zwitterionic Poly(epsilon-N-methacryloyl-L-lysine)
CD40 ligand promotes angiotensin-II induced vascular inflammation, thrombin sensitivity, oxidative stress and endothelial dysfunction
Supplementary material 1
Screening for Distress in Routine Oncological Care—A Survey in 520 Melanoma Patients
Angiotensin II-Induced Vascular Dysfunction Depends on Interferon- -Driven Immune Cell Recruitment and Mutual Activation of Monocytes and NK-Cells
The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells
S2k Kurzleitlinie - Merkelzellkarzinom: Merkelzellkarzinom
Brief S2k guidelines - Cutaneous squamous cell carcinoma: Cutaneous squamous cell carcinoma
S2k Kurzleitlinie - Plattenepithelkarzinom der Haut: Plattenepithelkarzinom
Brief S2k guidelines – Merkel cell carcinoma
25. Mainzer Allergie-Workshop
Supplementary Material
Serum S100B Levels Correlate with Clinical Benefit in a Metastatic Melanoma Patient Treated by CTLA-4 Blockade: A Case Report
Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
Missing publications? Read more about our data sources.